ONCO
Onconetix, Inc.
$1.01
-1.94%
$1.2M
No data for this timeframe.
Vol
Market Cap$1.2M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$17.00
Inst. Activity2 buys / 1 sells
Insider Activity3B / 3S
Insider Net $$8.4K
Reddit Sentiment62° Warm
SEC Reports7
Press Releases5
Recent Activity
Jun 1, 2026
earnings_calendar
ONCO Q4 2025 Earnings After Market Close — 2026-06-01
May 13, 2026
SEC
Onconetix provided a Q1 2026 operational update highlighting new clinical publications for Proclarix®, initiation of the
PRESS-RELEASE — Impact 3/10
May 8, 2026
SEC
The SEC declared effective Onconetix's S-1 registration (File No. 333-295376), enabling Keystone Capital Partners to imm
EFFECT — Impact 7/10
May 7, 2026
SEC
Onconetix filed Amendment No. 1 to its S-1 registration statement, purely to add Exhibit 5.1 (legal opinion from Ellenof
S-1/A — Impact 2/10
Apr 21, 2026
Insider
HRT FINANCIAL LP sold 49,710 shares
10%+ Owner @ $0.6900 ($34.3K)
Apr 20, 2026
Insider
HRT FINANCIAL LP sold 94,462 shares
10%+ Owner @ $0.7500 ($70.8K)
Apr 17, 2026
Insider
HRT FINANCIAL LP bought 34,636 shares
10%+ Owner @ $0.7300 ($25.3K)
Inst.
UBS Group AG — ADD
5,506 shares ($17.1K)
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 13, 2023 | Maxim Group | DOWNGRADE | Buy → Hold |
| Apr 26, 2023 | HC Wainwright & Co. | MAINTAIN | Buy |
| Feb 1, 2023 | HC Wainwright & Co. | REITERATE | Buy |
| Dec 9, 2022 | HC Wainwright & Co. | INITIATE | Buy |
| Dec 8, 2022 | Maxim Group | INITIATE | Buy |
Latest Reports
BEARISH
Press
5/10
Onconetix announces a 1-for-10 reverse stock split effective May 21, 2026, to regain compliance with Nasdaq's $1 minimum
May 19, 2026
NEUTRAL
PRESS-RELEASE
3/10
Onconetix provided a Q1 2026 operational update highlighting new clinical publications for Proclarix®, initiation of the
May 13, 2026
BEARISH
EFFECT
7/10
The SEC declared effective Onconetix's S-1 registration (File No. 333-295376), enabling Keystone Capital Partners to imm
May 8, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $17.00 | DOUBLED |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 21, 2026 | HRT FINANCIAL | SELL | $34.3K |
| Apr 20, 2026 | HRT FINANCIAL | SELL | $70.8K |
| Apr 17, 2026 | HRT FINANCIAL | BUY | $25.3K |
| Apr 16, 2026 | HRT FINANCIAL | SELL | $39.3K |
| Apr 15, 2026 | HRT FINANCIAL | BUY | $70.3K |
Reddit Sentiment
62°▲
Warm
Bearish
Neutral
Bullish
1 institutional holders with $17.00 total value (11 shares) as of 2025-Q4. Top holders: BANK.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 11 | $17.00 | 100.0% | DOUBLED +1000.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | ADD | 2,791 | 5,506 | +97.3% | $17.1K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 1 | 11 | +1000.0% | $34.00 | 2025-Q3 |
| MORGAN STANLEY | EXIT | 5,800 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | NEW | — | 5,800 | — | $27.7K | 2025-Q2 |
| UBS Group AG | NEW | — | 2,791 | — | $13.3K | 2025-Q2 |
1 unique insiders with 6 transactions. Net insider value: $8.4K ($152.9K bought, $144.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 21, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 49,710 | $0.6900 | $34.3K |
| Apr 20, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 94,462 | $0.7500 | $70.8K |
| Apr 17, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 34,636 | $0.7300 | $25.3K |
| Apr 16, 2026 | HRT FINANCIAL LP | 10%+ Owner | SELL | 53,867 | $0.7300 | $39.3K |
| Apr 15, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 92,554 | $0.7600 | $70.3K |
| Apr 14, 2026 | HRT FINANCIAL LP | 10%+ Owner | BUY | 74,350 | $0.7700 | $57.2K |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 5 neutral. Avg impact: 3.7/10.
NEUTRAL
PRESS-RELEASE
3/10
Onconetix provided a Q1 2026 operational update highlighting new clinical publications for Proclarix
May 13, 2026
BEARISH
EFFECT
7/10
The SEC declared effective Onconetix's S-1 registration (File No. 333-295376), enabling Keystone Cap
May 8, 2026
NEUTRAL
S-1/A
2/10
Onconetix filed Amendment No. 1 to its S-1 registration statement, purely to add Exhibit 5.1 (legal
May 7, 2026
NEUTRAL
8-K
3/10
Onconetix, Inc. announced the resignation of directors Andrew Oakley and Thomas Meier, the appointme
Apr 24, 2026
NEUTRAL
3
2/10
HRT FINANCIAL LP filed a Form 3 disclosing initial beneficial ownership of 104,498 Class A shares in
Apr 16, 2026
BULLISH
425
7/10
Onconetix appointed David White as CEO and Sammy Dorf to its board to strengthen leadership ahead of
Mar 31, 2026
NEUTRAL
3
2/10
David Allan White, CEO of Onconetix, Inc., filed a Form 3 disclosing his initial beneficial ownershi
Mar 27, 2026
BEARISH
5/10
Onconetix announces a 1-for-10 reverse stock split effective May 21, 2026, to regain compliance with
May 19, 2026
BULLISH
6/10
Onconetix highlighted the delivery of the first Vinci-equipped humanoid robot by Realbotix, its pend
Apr 9, 2026
MIXED
6/10
Onconetix shared a press release from Realbotix, the target of its pending all-stock acquisition, an
Apr 2, 2026
NEUTRAL
4/10
Onconetix announced the appointment of David White as CEO and Sammy Dorf to its Board of Directors a
Mar 31, 2026
BULLISH
7/10
Onconetix, Inc. (ONCO) announced that Realbotix, the target of its pending all-stock acquisition, ha
Mar 25, 2026
Historical analyst distribution (last covering-analyst action Sep 2023): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2023-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
2 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Sep 13, 2023 | Maxim Group | DOWNGRADE | Buy | Hold |
| Apr 26, 2023 | HC Wainwright & Co. | MAINTAIN | — | Buy |
| Feb 1, 2023 | HC Wainwright & Co. | REITERATE | — | Buy |
| Dec 9, 2022 | HC Wainwright & Co. | INITIATE | — | Buy |
| Dec 8, 2022 | Maxim Group | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
62°
Warm
Bearish
Neutral
Bullish
35 mentions
11 bullish
2 bearish
30 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 19, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 17, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 17, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| May 17, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| May 13, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 13, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 1, 2026 | 3 | 50° Neutral | 0 | 0 | 3 |
| May 1, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| May 1, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 27, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Apr 27, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Apr 27, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 27, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 21, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 21, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 14, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 14, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 9, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 9, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
$onco short ctb
▲ 1
💬 1
⚡ 0.5
ONCO TODAY PARTY
▲ 1
💬 1
⚡ 0.5
$ONCO Today !!
▲ 1
💬 1
⚡ 0.4
ONCO: A Degenerates’ Stock for My 1st WSB Post
▲ 1
💬 1
⚡ 0.5
ONCO: Degenerates Unite
▲ 1
💬 0
⚡ 0.5
ONCO: Degenerates Unite
▲ 1
💬 0
⚡ 0.5
ONCO ONCO ONCO ONCO
▲ 1
💬 1
⚡ 0.5
ONCO ONCONETIX signed new contract
▲ 1
💬 0
⚡ 0.5
ONCO will make 7000 per cent
▲ 1
💬 1
⚡ 0.5
How ONCO stock will react today?
▲ 1
💬 1
⚡ 0.5
ONCO JUMP HISTORICAL
▲ 1
💬 0
⚡ 0.5
ONCO JUMP HISTORICAL
▲ 1
💬 1
⚡ 0.5
ONCO JUMP HISTORICAL
▲ 1
💬 1
⚡ 0.5
ONCO STOCK HIT 80$ TODAY
▲ 1
💬 0
⚡ 0.5
Advice: ONCO 80 dollars
▲ 1
💬 0
⚡ 0.5
My next high conviction stock pick: $ONCO
▲ 1
💬 1
⚡ 0.5
Jun 1, 2026
earnings_calendar
ONCO Q4 2025 Earnings After Market Close — 2026-06-01
May 19, 2026
announcement
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
<p align="justify">CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-st
May 19, 2026
short_volume
Short Volume: ONCO — 67.7% short (16.3M / 24.1M)
Short: 16,334,973 | Exempt: 4,319,733 | TRF Vol: 24,117,408 | Short Ratio: 67.7% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings
Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study
<p align="center"><i>New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study I
Apr 27, 2026
short_volume
Short Volume: ONCO — 59.3% short (11.7M / 19.8M)
Short: 11,729,495 | Exempt: 2,586,408 | TRF Vol: 19,791,305 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)
Apr 16, 2026
short_volume
Short Volume: ONCO — 58.1% short (0.6M / 1.0M)
Short: 572,775 | Exempt: 104,820 | TRF Vol: 986,504 | Short Ratio: 58.1% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: ONCO — 58.8% short (1.2M / 2.0M)
Short: 1,167,459 | Exempt: 290,458 | TRF Vol: 1,985,158 | Short Ratio: 58.8% | Off-exchange volume (dark pool + OTC)
Apr 10, 2026
short_interest
FTD: ONCO — 7,621,141 shares ($9.3M) failed to deliver
Settlement: 20260410, Price: $1.22, FTD Value: $9,297,792.02, ONCONETIX, INC. COMMON STOCK C
Apr 9, 2026
announcement
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
<p align="center"><i>Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a
Apr 9, 2026
short_volume
Short Volume: ONCO — 55.7% short (59.7M / 107.0M)
Short: 59,661,499 | Exempt: 10,857,173 | TRF Vol: 107,033,709 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
announcement
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
<p align="center"><i>Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix rece
Apr 2, 2026
short_interest
FTD: ONCO — 497,098 shares ($0.9M) failed to deliver
Settlement: 20260402, Price: $1.88, FTD Value: $934,544.24, ONCONETIX, INC. COMMON STOCK C
Apr 1, 2026
short_interest
FTD: ONCO — 1,375,572 shares ($2.0M) failed to deliver
Settlement: 20260401, Price: $1.49, FTD Value: $2,049,602.28, ONCONETIX, INC. COMMON STOCK C
Apr 1, 2026
short_volume
Short Volume: ONCO — 58.6% short (0.7M / 1.2M)
Short: 701,069 | Exempt: 62,753 | TRF Vol: 1,196,001 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)
Mar 31, 2026
announcement
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors
<p align="center"><i>Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix LLC and Drive Long-Term Shareho